Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | 20.4x - 22.6x | 21.5x |
| Selected Fwd P/E Multiple | 5.4x - 6.0x | 5.7x |
| Fair Value | ¥1,313 - ¥1,451 | ¥1,382 |
| Upside | 22.7% - 35.6% | 29.2% |
| Benchmarks | - | Full Ticker |
| Rohto Pharmaceutical Co.,Ltd. | 452,700.0% | TSE:4527 |
| Shinnihonseiyaku Co., Ltd. | 493,100.0% | TSE:4931 |
| Artnature Inc. | 782,300.0% | TSE:7823 |
| Shiseido Company, Limited | 491,100.0% | TSE:4911 |
| HABA Laboratories,Inc. | 492,500.0% | TSE:4925 |
| Nippon Shikizai, Inc. | 492,000.0% | TSE:4920 |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| 4527 | 4931 | 7823 | 4911 | 4925 | 4920 | |||
| TSE:4527 | TSE:4931 | TSE:7823 | TSE:4911 | TSE:4925 | TSE:4920 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 15.0% | 8.9% | -11.8% | NM- | -15.2% | -5.3% | ||
| 3Y CAGR | 13.8% | 6.5% | -12.0% | NM- | NM- | NM- | ||
| Latest Twelve Months | 13.1% | -8.1% | -23.8% | -112.9% | 133.2% | -70.4% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 10.6% | 6.7% | 3.1% | 1.9% | -3.9% | -0.9% | ||
| Prior Fiscal Year | 11.4% | 6.4% | 3.4% | 2.2% | -17.2% | 2.6% | ||
| Latest Fiscal Year | 10.0% | 7.0% | 1.9% | -1.1% | 4.8% | 1.2% | ||
| Latest Twelve Months | 10.6% | 6.1% | 1.7% | -0.1% | 5.3% | 0.7% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 10.1x | 6.9x | 3.0x | 14.1x | 4.5x | 8.3x | ||
| Price / LTM Sales | 1.8x | 1.3x | 0.6x | 1.1x | 0.5x | 0.1x | ||
| LTM P/E Ratio | 16.9x | 21.0x | 36.3x | -790.1x | 10.2x | 18.7x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -790.1x | 16.9x | 36.3x | |||||
| Historical LTM P/E Ratio | -11.4x | 7.2x | 27.8x | |||||
| Selected P/E Multiple | 20.4x | 21.5x | 22.6x | |||||
| (x) LTM Net Income | 120 | 120 | 120 | |||||
| (=) Equity Value | 2,451 | 2,580 | 2,708 | |||||
| (/) Shares Outstanding | 2.1 | 2.1 | 2.1 | |||||
| Implied Value Range | 1,169.27 | 1,230.81 | 1,292.35 | |||||
| FX Rate: JPY/JPY | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 1,169.27 | 1,230.81 | 1,292.35 | 1,070.00 | ||||
| Upside / (Downside) | 9.3% | 15.0% | 20.8% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4527 | 4931 | 7823 | 4911 | 4925 | 4920 | |
| Value of Common Equity | 580,841 | 52,696 | 26,861 | 1,022,384 | 6,504 | 2,242 | |
| (/) Shares Outstanding | 226.0 | 21.1 | 32.6 | 399.5 | 3.8 | 2.1 | |
| Implied Stock Price | 2,570.50 | 2,493.00 | 825.00 | 2,559.00 | 1,720.00 | 1,070.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 2,570.50 | 2,493.00 | 825.00 | 2,559.00 | 1,720.00 | 1,070.00 | |
| Trading Currency | JPY | JPY | JPY | JPY | JPY | JPY | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |